-DOCSTART- -X- O
PURPOSE -X- _ O
: -X- _ O
Acute -X- _ O
otitis -X- _ O
media -X- _ O
( -X- _ O
AOM -X- _ O
) -X- _ O
is -X- _ O
a -X- _ O
common -X- _ O
infectious -X- _ O
disease -X- _ O
in -X- _ O
children -X- _ O
and -X- _ O
usually -X- _ O
accompanied -X- _ O
by -X- _ O
a -X- _ O
preceding -X- _ O
viral -X- _ O
respiratory -X- _ O
tract -X- _ O
infection -X- _ O
, -X- _ O
especially -X- _ O
in -X- _ O
the -X- _ O
preschool-age -X- _ O
population. -X- _ O
The -X- _ O
study -X- _ O
aimed -X- _ O
to -X- _ O
evaluate -X- _ O
impact -X- _ O
of -X- _ O
influenza -X- _ O
vaccine -X- _ O
on -X- _ O
childhood -X- _ B-Patient
otitis -X- _ I-Patient
media. -X- _ I-Patient
METHODS -X- _ O
: -X- _ O
This -X- _ O
retrospective -X- _ O
cohort -X- _ O
study -X- _ O
included -X- _ O
data -X- _ O
for -X- _ O
803,592 -X- _ O
children -X- _ B-Patient
( -X- _ I-Patient
< -X- _ I-Patient
10 -X- _ I-Patient
years -X- _ I-Patient
old -X- _ I-Patient
) -X- _ I-Patient
recorded -X- _ O
in -X- _ O
Taiwan’s -X- _ O
National -X- _ O
Health -X- _ O
Insurance -X- _ O
Research -X- _ O
Database. -X- _ O
AOM -X- _ O
incidence -X- _ O
and -X- _ O
tympanostomy -X- _ O
tube -X- _ O
insertion -X- _ O
incidence -X- _ O
in -X- _ O
each -X- _ O
influenza -X- _ O
season -X- _ O
before -X- _ O
and -X- _ O
after -X- _ O
the -X- _ O
introduction -X- _ O
of -X- _ O
traditional -X- _ B-Intervention
injectable -X- _ I-Intervention
trivalent -X- _ I-Intervention
influenza -X- _ I-Intervention
vaccine -X- _ I-Intervention
( -X- _ I-Intervention
TIV -X- _ I-Intervention
) -X- _ I-Intervention
were -X- _ O
compared -X- _ O
using -X- _ O
the -X- _ O
Poisson -X- _ O
regression -X- _ O
analysis -X- _ O
to -X- _ O
estimate -X- _ O
the -X- _ O
incidence -X- _ O
rate -X- _ O
ratios -X- _ O
( -X- _ O
IRRs -X- _ O
) -X- _ O
and -X- _ O
95 -X- _ O
% -X- _ O
confidence -X- _ O
intervals -X- _ O
( -X- _ O
CIs -X- _ O
) -X- _ O
. -X- _ O
RESULTS -X- _ O
: -X- _ O
In -X- _ O
children -X- _ O
< -X- _ O
2 -X- _ O
years -X- _ O
old -X- _ O
, -X- _ O
the -X- _ O
age -X- _ O
group -X- _ O
eligible -X- _ O
for -X- _ O
free -X- _ O
influenza -X- _ O
vaccination -X- _ O
, -X- _ O
there -X- _ O
was -X- _ O
a -X- _ O
significant -X- _ O
reduction -X- _ O
in -X- _ O
seasonal -X- _ B-Outcome
AOM -X- _ I-Outcome
incidence -X- _ I-Outcome
after -X- _ I-Outcome
TIV -X- _ I-Outcome
introduction -X- _ I-Outcome
in -X- _ I-Outcome
2004 -X- _ I-Outcome
( -X- _ I-Outcome
from -X- _ I-Outcome
98.4 -X- _ I-Outcome
episodes -X- _ I-Outcome
/ -X- _ I-Outcome
1000 -X- _ I-Outcome
person-seasons -X- _ I-Outcome
[ -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
: -X- _ I-Outcome
96.4–100.5 -X- _ I-Outcome
] -X- _ I-Outcome
to -X- _ I-Outcome
66.1 -X- _ I-Outcome
episodes -X- _ I-Outcome
/ -X- _ I-Outcome
1000 -X- _ I-Outcome
person-seasons -X- _ I-Outcome
[ -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
: -X- _ I-Outcome
64–68.1 -X- _ I-Outcome
] -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
In -X- _ O
addition -X- _ O
, -X- _ O
with -X- _ B-Outcome
the -X- _ I-Outcome
increased -X- _ I-Outcome
vaccine -X- _ I-Outcome
coverage -X- _ I-Outcome
rate -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
outpatient -X- _ I-Outcome
visits -X- _ I-Outcome
for -X- _ I-Outcome
AOM -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
influenza -X- _ I-Outcome
season -X- _ I-Outcome
of -X- _ I-Outcome
2005 -X- _ I-Outcome
and -X- _ I-Outcome
2006 -X- _ I-Outcome
were -X- _ I-Outcome
significantly -X- _ I-Outcome
lower -X- _ I-Outcome
than -X- _ I-Outcome
that -X- _ I-Outcome
in -X- _ I-Outcome
2004 -X- _ I-Outcome
( -X- _ I-Outcome
IRR -X- _ I-Outcome
= -X- _ I-Outcome
0.85 -X- _ I-Outcome
and -X- _ I-Outcome
0.80 -X- _ I-Outcome
, -X- _ I-Outcome
respectively -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
< -X- _ I-Outcome
0.0001 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
CONCLUSIONS -X- _ O
: -X- _ O
A -X- _ O
significant -X- _ O
reduction -X- _ B-Outcome
in -X- _ I-Outcome
primary -X- _ I-Outcome
care -X- _ I-Outcome
consultations -X- _ I-Outcome
for -X- _ I-Outcome
children -X- _ I-Outcome
< -X- _ I-Outcome
2 -X- _ I-Outcome
years -X- _ I-Outcome
old -X- _ I-Outcome
was -X- _ I-Outcome
observed -X- _ I-Outcome
after -X- _ I-Outcome
the -X- _ I-Outcome
introduction -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
TIV -X- _ I-Outcome
in -X- _ I-Outcome
Taiwan -X- _ I-Outcome
in -X- _ I-Outcome
2004. -X- _ I-Outcome
With -X- _ O
the -X- _ O
increased -X- _ O
vaccine -X- _ O
coverage -X- _ O
, -X- _ O
there -X- _ O
was -X- _ O
an -X- _ O
additional -X- _ O
decline -X- _ O
in -X- _ O
2005 -X- _ O
and -X- _ O
2006. -X- _ O
In -X- _ O
addition -X- _ O
of -X- _ O
the -X- _ O
direct -X- _ O
protection -X- _ O
provided -X- _ O
by -X- _ O
the -X- _ O
vaccination -X- _ O
, -X- _ O
we -X- _ O
believe -X- _ O
that -X- _ O
TIV -X- _ O
may -X- _ O
have -X- _ O
induced -X- _ O
some -X- _ O
herd -X- _ O
immunity -X- _ O
that -X- _ O
further -X- _ O
contributed -X- _ O
to -X- _ O
the -X- _ O
reduction -X- _ O
in -X- _ O
influenza -X- _ O
attack -X- _ O
rates -X- _ O
and -X- _ O
the -X- _ O
rates -X- _ O
of -X- _ O
associated -X- _ O
AOM -X- _ O
in -X- _ O
that -X- _ O
age -X- _ O
group. -X- _ O
These -X- _ O
reductions -X- _ O
were -X- _ O
observed -X- _ O
only -X- _ O
in -X- _ O
vaccine-eligible -X- _ O
children -X- _ O
, -X- _ O
while -X- _ O
older -X- _ O
children -X- _ O
, -X- _ O
who -X- _ O
were -X- _ O
not -X- _ O
enrolled -X- _ O
in -X- _ O
the -X- _ O
influenza -X- _ O
vaccination -X- _ O
program -X- _ O
during -X- _ O
the -X- _ O
study -X- _ O
period -X- _ O
, -X- _ O
have -X- _ O
experienced -X- _ O
increases -X- _ O
in -X- _ O
the -X- _ O
AOM -X- _ O
incidence -X- _ O
during -X- _ O
the -X- _ O
2004–2006 -X- _ O
period -X- _ O
compared -X- _ O
to -X- _ O
the -X- _ O
2000–2003 -X- _ O
period -X- _ O
. -X- _ O

